| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/21/2013 | US8445230 Immunosuppressive polypeptides and nucleic acids |
| 05/21/2013 | US8445229 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 05/21/2013 | US8445193 Microwell array chip for detecting antigen-specific lymphocytes, method of detecting and method of manufacturing antigen-specific lymphocytes, and method of cloning antigen-specific lymphocyte antigen receptor genes |
| 05/21/2013 | US8445191 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 05/21/2013 | US8445006 Biomolecular coating for implants |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444987 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/21/2013 | US8444986 Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof |
| 05/21/2013 | US8444985 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 05/21/2013 | US8444982 Anti-IGF-IR antibodies and uses thereof |
| 05/21/2013 | US8444981 Alpha-4 beta-7 heterodimer specific antagonist antibody |
| 05/21/2013 | US8444980 Therapeutic use of anti-CS1 antibodies |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | US8444978 Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 |
| 05/21/2013 | US8444976 Antigen binding polypeptides |
| 05/21/2013 | US8444974 Use of antibodies for the vaccination against cancer |
| 05/21/2013 | US8444972 Antitumor antibodies, proteins, and uses thereof |
| 05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
| 05/21/2013 | CA2707766C Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 05/21/2013 | CA2561830C Monoclonal antibodies with specificity for fetal erythroid cells |
| 05/21/2013 | CA2560782C Methods and compositions for the detection of cervical disease |
| 05/21/2013 | CA2478011C Bispecific antibody point mutations for enhancing rate of clearance |
| 05/21/2013 | CA2477675C Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2370405C Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch |
| 05/21/2013 | CA2360146C Methods for inhibiting brain tumor growth by using selected integrin antagonists |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/16/2013 | WO2013071127A1 Monoclonal antibodies against serotransferrin antigens, and uses therefor |
| 05/16/2013 | WO2013071058A1 Her3 antibodies and uses thereof |
| 05/16/2013 | WO2013071055A1 Assay for diabetes-associated autoantibodies |
| 05/16/2013 | WO2013071016A2 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 05/16/2013 | WO2013070821A1 Methods and compositions for treating diseases, disorders or injury of the nervous system |
| 05/16/2013 | WO2013070776A1 Neutralizing gp41 antibodies and their use |
| 05/16/2013 | WO2013070619A1 Indolealkylamino-withasteroid conjugates and method of use |
| 05/16/2013 | WO2013070615A1 Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | WO2013069741A1 Antibody specific to profilaggrin c-terminal domain, and use thereof |
| 05/16/2013 | WO2013068946A2 Antibodies specific for trop-2 and their uses |
| 05/16/2013 | WO2013068902A1 Methods of treating inflammatory disorders using anti-m-csf antibodies |
| 05/16/2013 | WO2013068758A1 Antibody specific for trans - resveratrol and use thereof |
| 05/16/2013 | WO2013068571A1 Albumin binding antibodies and binding fragments thereof |
| 05/16/2013 | WO2013068563A2 Antibody molecules having specificity for human ox40 |
| 05/16/2013 | WO2013001369A3 Therapeutic and diagnostic target |
| 05/16/2013 | WO2012136790A9 Compositions comprising fusion proteins or conjugates with an improved serum half-life |
| 05/16/2013 | US20130125252 Novel anti-igf-ir antibodies and uses thereof |
| 05/16/2013 | US20130123472 Novel antigen binding proteins |
| 05/16/2013 | US20130123471 Antibody Against Carcinoembryonic Antigen and Uses Thereof |
| 05/16/2013 | US20130123465 Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
| 05/16/2013 | US20130123122 Secreted proteins and uses thereof |
| 05/16/2013 | US20130122052 Antibody mediated osseous regeneration |
| 05/16/2013 | US20130122047 Streptococcus pyogenes antigens |
| 05/16/2013 | US20130122030 S. epidermidis antigens |
| 05/16/2013 | US20130122024 New binder-drug conjugates (adcs) and use thereof |
| 05/16/2013 | US20130122022 Sequence of stro-1 antibody variable region |
| 05/16/2013 | US20130122020 Antibodies specific for trop-2 and their uses |
| 05/16/2013 | US20130122019 Anti-human alpha9 integrin antibody and use thereof |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130122015 Antibody and methods for selective inhibition of t-cell responses |
| 05/16/2013 | US20130122014 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 05/16/2013 | US20130122013 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 05/16/2013 | US20130122012 Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof |
| 05/16/2013 | US20130122011 Multiple-variable dose regimen for treating TNFa-related disorders |
| 05/16/2013 | US20130122009 Engineered Anti-IL-23p19 Antibodies |
| 05/16/2013 | US20130122007 Compositions and Methods for Increasing Muscle Mass and Muscle Strength by Specifically Antagonizing GDF8 and or Activin A |
| 05/16/2013 | US20130122006 Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis |
| 05/16/2013 | US20130122003 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 05/16/2013 | US20130122002 Methods for cancer management targeting co-029 |
| 05/16/2013 | US20130122001 Antibody variants with enhanced complement activity |
| 05/16/2013 | US20130122000 Antibodies immunoreactive with heregulin-coupled her3 |
| 05/16/2013 | US20130121997 Binding agents |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | US20130121993 Compositions and Methods for Treating and Diagnosing Cancer |
| 05/16/2013 | US20130121992 Molecules and methods for treatment of diabetes |
| 05/16/2013 | US20130121913 Anti-CD19 Antibodies |
| 05/16/2013 | DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus |
| 05/16/2013 | CA2856216A1 Albumin binding antibodies and binding fragments thereof |
| 05/16/2013 | CA2856200A1 Antibody specific for trans-resveratrol and use thereof |
| 05/16/2013 | CA2856149A1 Methods of treating inflammatory disorders using anti-m-csf antibodies |
| 05/16/2013 | CA2855174A1 Antibody molecules having specificity for human ox40 |
| 05/16/2013 | CA2855155A1 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
| 05/16/2013 | CA2854817A1 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | CA2854806A1 Multispecific and multivalent binding proteins and uses thereof |
| 05/16/2013 | CA2854720A1 Antibodies specific for trop-2 and their uses |
| 05/16/2013 | CA2853836A1 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 05/15/2013 | EP2592421A1 Diagnosis of sepsis and systemic inflammatory response syndrome |
| 05/15/2013 | EP2592148A1 Protein expression from multiple nucleic acids |
| 05/15/2013 | EP2592147A1 Protein expression from multiple nucleic acids |
| 05/15/2013 | EP2592094A1 Binding members for IgE molecules |
| 05/15/2013 | EP2592093A1 Human c-fms antigen binding proteins |
| 05/15/2013 | EP2591822A1 Treatment of diseases |
| 05/15/2013 | EP2591006A1 Processable single chain molecules and polypeptides made using same |
| 05/15/2013 | EP2591005A2 Anti-ron antibodies |
| 05/15/2013 | EP2591004A1 Anti-neuropilin antibodies and methods of use |
| 05/15/2013 | EP2591003A1 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 05/15/2013 | EP2591002A2 Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (vegfr- 2 /kdr) |
| 05/15/2013 | EP2591001A1 Agonistic antibody to cd27 |
| 05/15/2013 | EP2591000A2 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 05/15/2013 | EP2590999A1 Lipid-conjugated antibodies |